Multiple Sclerosis (MS)

  1. Ocrevus (ocrelizumab)
    Ocrevus (ocrelizumab)
    by Roche Registration Limited
    for Multiple Sclerosis
    €7,187.50
  2. Mavenclad (cladribine)
    Mavenclad (cladribine)
    by Merck Serono Europe Limited
    for Multiple Sclerosis
    €2,587.50
View as Grid List

2 Items

per page
Set Descending Direction